levodopa 42 MG Inhalation Powder Capsule

RxCUI: 2107616
RxNorm name: levodopa 42 MG Inhalation Powder Capsule
Display name: levodopa 42 MG Inhalation Powder Capsule
Full name: levodopa 42 MG Inhalation Powder Capsule
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:14

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Inbrija	LEVODOPA	Merz Pharmaceuticals, LLC	077c0f39-a3a2-4b2b-a184-09131889dcfb	2026-07-20	Warnings, Adverse reactions	Exact identifier rxcui: 2107616
Inbrija	LEVODOPA	Merz Pharmaceuticals, LLC	a906f8e1-6e1c-480a-8276-c01bc65dd3be	2026-01-16	Warnings, Adverse reactions	Exact identifier rxcui: 2107616

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
a906f8e1-6e1c-480a-8276-c01bc65dd3be	levodopa 42 MG Inhalation Powder Capsule	PSN	13	These highlights do not include all the information needed to use INBRIJA safely and effectively. See full prescribing information for INBRIJA. INBRIJA ® (levodopa inhalation powder), for oral inhalation use Initial U.S. Approval: 1970	20260116
a906f8e1-6e1c-480a-8276-c01bc65dd3be	levodopa 42 MG Inhalation Powder	SCD	13	These highlights do not include all the information needed to use INBRIJA safely and effectively. See full prescribing information for INBRIJA. INBRIJA ® (levodopa inhalation powder), for oral inhalation use Initial U.S. Approval: 1970	20260116
a906f8e1-6e1c-480a-8276-c01bc65dd3be	L-DOPA 42 MG Inhalation Powder	SY	13	These highlights do not include all the information needed to use INBRIJA safely and effectively. See full prescribing information for INBRIJA. INBRIJA ® (levodopa inhalation powder), for oral inhalation use Initial U.S. Approval: 1970	20260116
077c0f39-a3a2-4b2b-a184-09131889dcfb	levodopa 42 MG Inhalation Powder Capsule	PSN	1	These highlights do not include all the information needed to use INBRIJA safely and effectively. See full prescribing information for INBRIJA. INBRIJA ® (levodopa inhalation powder), for oral inhalation use Initial U.S. Approval: 1970	20250922
077c0f39-a3a2-4b2b-a184-09131889dcfb	L-DOPA 42 MG Inhalation Powder	SY	1	These highlights do not include all the information needed to use INBRIJA safely and effectively. See full prescribing information for INBRIJA. INBRIJA ® (levodopa inhalation powder), for oral inhalation use Initial U.S. Approval: 1970	20250922
077c0f39-a3a2-4b2b-a184-09131889dcfb	levodopa 42 MG Inhalation Powder	SCD	1	These highlights do not include all the information needed to use INBRIJA safely and effectively. See full prescribing information for INBRIJA. INBRIJA ® (levodopa inhalation powder), for oral inhalation use Initial U.S. Approval: 1970	20250922